Calcium Propionate vs Erythritol: which is worse?

What is Calcium Propionate?

Calcium propionate is the calcium salt of propionic acid, a short-chain fatty acid naturally produced during fermentation. It is one of the most widely used mold inhibitors in commercial bread and baked goods. It works by penetrating fungal cells and lowering internal pH to inhibit growth.

What is Erythritol?

Erythritol is a four-carbon sugar alcohol naturally occurring in small amounts in fruits, fermented foods, and mushrooms. Commercially produced via fermentation of glucose by yeasts such as Moniliella pollinis, it has approximately 70% of sucrose's sweetness, provides 0.24 kcal/g, and has a glycemic index of 0. It is nearly completely absorbed in the small intestine and excreted unchanged in urine, which explains its unusually low laxative effect compared to other polyols.

Documented risks

Calcium Propionate: Generally recognized as safe. However, a 2012 study in the Journal of Pediatric Child Health (Dengate & Ruben) and a 2019 study published in Science Translational Medicine found that calcium propionate induced insulin resistance in a mouse model and raised metabolic concerns. The 2019 animal study, conducted by Bhatt et al., found that propionate triggered glucagon and norepinephrine secretion. Some open-label human studies and parental reports have linked calcium propionate to irritability, sleep disturbance, and behavioral changes in sensitive children, though these lack robust clinical trial evidence. Most regulatory agencies consider it safe at current use levels.

Erythritol: A 2023 observational study published in Nature Medicine (Hazen et al., Cleveland Clinic) found that elevated blood erythritol levels were associated with increased risk of major adverse cardiovascular events (MACE), including heart attack and stroke. Additionally, erythritol was found to enhance platelet aggregation in vitro. This study was widely reported and has generated significant scientific debate; critics note that it was observational (not causational), and that the study population had pre-existing cardiovascular risk factors. Regulatory agencies have not changed their approval status. The long-term cardiovascular implications require further research.